BBP
$67.56
Virtus LifeSci Biotech Products ETF
Fund Family: ETFis Series Trust I
1 Month
+9.18%
YTD
+5.45%
1 Year
+5.45%
3 Year
+42.44%
Top 10 Holdings (22.9% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | TG Therapeutics, Inc. | TGTX | Manufacturing | 2.58% |
| 2 | BeiGene Ltd | ONC | Unknown | 2.50% |
| 3 | Bridgebio Pharma Inc | BBIO | Manufacturing | 2.41% |
| 4 | MOTION FINCO SARL | KNSA | Manufacturing | 2.33% |
| 5 | Ascendis Pharma A/S | ASND | Manufacturing | 2.27% |
| 6 | Sage Therapeutics Inc | SG7 | Unknown | 2.24% |
| 7 | Halozyme Therapeutics, Inc. | HALO | Manufacturing | 2.23% |
| 8 | ADMA Biologics, Inc. | ADMA | Manufacturing | 2.22% |
| 9 | SpringWorks Therapeutics Inc | 85205L107 | Unknown | 2.08% |
| 10 | Axsome Therapeutics Inc | AXSM | Manufacturing | 2.07% |
Fund Information
| Net Assets | $23.61M | Expense Ratio | N/A |
| Total Holdings | 63 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | ETFis Series Trust I |
*Annual fee per $10,000 invested